NEW YORK, March 27, 2017 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Caterpillar, Inc. securities (NYSE:CAT) from February 19, 2013 through March 1, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Caterpillar investors under the federal securities laws.
To join the Caterpillar class action, go to http://rosenlegal.com/cases-1068.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The complaint alleges that defendants during the Class Period made false and misleading statements and/or failed to disclose that: (1) Caterpillar unlawfully used foreign subsidiaries to avoid paying billions of dollars in U.S. taxes; (2) discovery of such conduct would subject Caterpillar to heightened regulatory scrutiny and potential criminal sanctions; and (3) as a result, Caterpillar’s public statements were materially false and misleading at all relevant times. On March 2, 2017, law enforcement officials raided Caterpillar’s facilities in Peoria, Illinois. Later that day, Caterpillar indicated that it believed the raid is related to, among other things, export filings of its Swiss subsidiary Caterpillar SARL. On this news, shares of Caterpillar fell $4.22 or 4.28% to close at $94.36 per share on March 2, 2017, damaging investors.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 2, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1068.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com


Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
Meta Expands AI Training With Employee Activity Tracking Tools
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 



